Skip to search formSkip to main contentSkip to account menu

Rifaprim

Known as: 3-(((4-methyl-1-piperazinyl)imino)methyl)rifamycin, mixt. with 5-((3,4,5-trimethoxyphenyl) methyl)-2,4-pyrimidinediamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
In vitro activity of 13 antibiotics and drug preparations as well as some of their combinations was studied with respect to… 
1983
1983
Two regimes of rifaprim (RPM), a 3.75 to 1 combination of rifampicin (RIF) and trimethoprim (TMP), were compared with co… 
Review
1982
Review
1982
Experimental data, pharmacokinetic results, and clinical trials suggest that trimethoprim (TMP) is effective when used alone and… 
1981
1981
Ten healthy volunteers were given 'Rifaprim' in the dosage recommended for the treatment of urinary infections in man (rifampicin… 
1979
1979
A controlled clinical trial of Rifaprim (rifampicin 600 mg plus trimethoprim 160 mg, in a single daily dose at 10 p.m.) and…